Inquire About a Product| Product: | Rapamycin-16-d3 | ||||
|---|---|---|---|---|---|
| Catalog Number: | D3296 | ||||
| Unlabeled CAS Number: | 53123-88-9 | ||||
| CAS Number: | 392711-19-2 | ||||
| Synonyms: |
Sirolimus-d3, (-)-Rapamycin-d3; AY 22989-d3; Antibiotic AY 22989-d3; Cypher-d3; NSC 226080-d3; RAPA-d3;; RPM-d3; Rapammune-d3; Rapamune-d3; SIIA 9268A-d3; Sirolimus-d3; Wy 090217-d3 |
||||
| Pricing: |
|
||||
| Formula: | C51H76D3NO13 | ||||
| Molecular Weight: | 917.19 | ||||
| Structure: |
|
||||
| Category: | Labeled Reference Standards | ||||
| Stability: | Stable under recommended storage conditions. | ||||
| Storage: |
-20°C Freezer, Under Inert Atmosphere, temperature and moisture sensitive |
||||
| Transportation: |
Non-hazardous for transport |
||||
| Literature References: |
McAlister VC, Mahalati K, Peltekian KM, Fraser A, MacDonald AS., A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.Ther Drug Monit., 2002, June, 24(3): 346–50.; Morelon E, Stern M, Israël-Biet D et al., Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation, 2001, Sep., 72 (5): 787–90. |
||||
| MSDS: | |||||
| Applications: | A labeled immunosuppressant and antiproliferative. May be useful in the treatment of some cancers. Prevents the activation of T and B cells. Used to prevent rejection from organ transplantation. Used with coronary stents to prevent restenosis in coronary arteries. |